GlassScriptPhysician profile
Jonathon Christopher Rutt
NPI 1689343402
$3,359.37
in general payments reported to CMS, 2019-2025
32 companies · $1,084 in 2025
The $1,084 reported for 2025 was more than what 84% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $274 · 2022: $879 · 2023: $579 · 2024: $543 · 2025: $1,084.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,206.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,205.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,480.09 | 2021-2025 | |
| Gilead Sciences, INC. | $364.87 | 2021-2023 | |
| Novo Nordisk INC | $249.05 | 2024-2025 | Ozempic, Wegovy, Rybelsus |
| Glaxosmithkline, LLC. | $142.33 | 2022-2025 | Trelegy Ellipta, Arexvy, Bexsero |
| Lilly USA, LLC | $116.12 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Pfizer INC. | $99.88 | 2024-2025 | |
| Amgen INC. | $83.33 | 2022-2024 | Krystexxa, Repatha, Otezla |
| Astellas Pharma US INC | $67.96 | 2025 | Veozah |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $60.66 | 2025 | Caplyta |
| Redhill Biopharma INC. | $60.34 | 2021-2022 | |
| Nestle Healthcare Nutrition INC. | $57.77 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $55.42 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $49.21 | 2024 | Lifevest |
| Sanofi Pasteur INC. | $48.15 | 2021-2022 | |
| Phadia US INC. | $39.95 | 2023 | Immunocap |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lucid Diagnostics INC. | $38.26 | 2022-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $36.75 | 2022 | |
| Novartis Pharmaceuticals Corporation | $36.62 | 2022 | |
| Tolmar, INC. | $35.60 | 2025 | Jatenzo |
| Seqirus USA INC | $30.29 | 2024 | Fluad, Flucelvax |
| Astrazeneca Pharmaceuticals LP | $27.78 | 2024-2025 | Airsupra |
| Alkermes, INC. | $23.89 | 2022 | |
| Renalytix Ai, INC. | $20.32 | 2025 | Kidneyintelx Blood Collection Convenience Kit |
| Lundbeck LLC | $18.35 | 2025 | Rexulti |
| Sumitomo Pharma America, INC. | $16.45 | 2025 | Gemtesa |
| Biogen, INC. | $15.99 | 2024 | Spinraza |
| Biohaven Pharmaceuticals, INC. | $15.88 | 2021 | |
| Amarin Pharma, INC. | $15.75 | 2022 | |
| Abbott Laboratories | $15.18 | 2025 | Freestyle Libre 3 |
| Inspire Medical Systems, INC. | $14.65 | 2025 | Inspire |
| Merck Sharp & Dohme LLC | $13.68 | 2025 | Gardasil 9, Capvaxive |
| Phathom Pharmaceuticals, INC. | $8.80 | 2025 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathon Rutt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.